Pitch Boonrak

Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ ritonavir, in pretreated children at 96 weeks

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2009, Antiviral therapy.

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

W. Wijagkanalan, C. Siegrist, S. Lawpoolsri, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Double Boosted Protease Inhibitors, Saquinavir, and Lopinavir/Ritonavir, in Nucleoside Pretreated Children at 48 Weeks

J. Ananworanich, K. Ruxrungtham, T. Bunupuradah, 2008, The Pediatric infectious disease journal.

Pattern and Predictors of Immunologic Recovery in Human Immunodeficiency Virus-Infected Children Receiving Non-Nucleoside Reverse Transcriptase Inhibitor-Based Highly Active Antiretroviral Therapy

J. Ananworanich, S. Kerr, T. Puthanakit, 2009, The Pediatric infectious disease journal.

Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.

J. Ananworanich, K. Ruxrungtham, T. Puthanakit, 2009, The Journal of antimicrobial chemotherapy.

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

J. Ananworanich, K. Ruxrungtham, W. Prasitsuebsai, 2011, AIDS research and therapy.

Attitudes of Thai caregivers of children with HIV infection towards HIV disclosure

J. Ananworanich, T. Bunupuradah, W. Apateerapong, 2007 .

Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.